✦ LIBER ✦

Can overexpression of parkin provide a novel strategy for neuroprotection in Parkinson's disease?

✍ Scribed by Ayse Ulusoy; Deniz Kirik

Book ID: 116459351
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 150 KB
Volume: 212
Category: Article
ISSN: 0014-4886
DOI: 10.1016/j.expneurol.2008.04.026

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Can Calcium Antagonists Provide a Neurop

Can Calcium Antagonists Provide a Neuroprotective Effect in Parkinson’s Disease?

✍ Robert L. Dr Rodnitzky 📂 Article 📅 1999 🏛 Springer International Publishing AG 🌐 English ⚖ 130 KB

Can parkin be a target for future treatm

Can parkin be a target for future treatment of Parkinson's disease?

✍ Kubo, Shin-ichiro; Hatano, Taku; Takanashi, Masashi; Hattori, Nobutaka 📂 Article 📅 2013 🏛 Informa plc 🌐 English ⚖ 556 KB

Encapsulated cell biodelivery of GDNF: A

Encapsulated cell biodelivery of GDNF: A novel clinical strategy for neuroprotection and neuroregeneration in Parkinson's disease?

✍ Olle Lindvall; Lars U. Wahlberg 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 586 KB

3.020 DJ-1 BASED PEPTIDE AS A NOVEL NEUR

3.020 DJ-1 BASED PEPTIDE AS A NOVEL NEUROPROTECTIVE STRATEGY IN PARKINSON'S DISEASE

✍ N. Lev; Y. Barhum; T. Ben-Zur; E. Melamed; D. Offen 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 57 KB

Novel NOX2 Inhibitor Suppresses Neuroinf

Novel NOX2 Inhibitor Suppresses Neuroinflammation in Experimental Models of Parkinson's Disease: A New Translational Strategy in Neuroprotection

✍ Anumantha G. Kanthasamy; Anamitra Ghosh; Joy Joseph; Colleen Hogan; Vellareddy A 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 177 KB

Neuroprotective therapy in Parkinson's d

Neuroprotective therapy in Parkinson's disease and motor complications: A search for a pathogenesis-targeted, disease-modifying strategy

✍ C. Warren Olanow; Joseph Jankovic 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB 👁 1 views

The introduction of levodopa in the late 1960s represented a landmark in the therapy of Parkinson's disease (PD). However, motor complications of chronic levodopa therapy have emerged as a major limitation of this otherwise effective therapy. Advancing medical and surgical treatment of these complic